February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Raffaele Colombo: Application based on results from the TROPION-Lung01 phase 3 trial
Feb 22, 2024, 18:56

Raffaele Colombo: Application based on results from the TROPION-Lung01 phase 3 trial

Raffaele Colombo, Principal Scientist & Group Lead, Medicinal Chemistry at Zymeworks, shared on X/Twitter:

“Application based on results from the TROPION-Lung01 phase 3 trial.

If approved, datopotamab deruxtecan (dato-DXd) may be the first TROP2 directed antibody drug conjugate for patients with lung cancer.”

Raffaele Colombo: Application based on results from the TROPION-Lung01 phase 3 trial

Further details.
Source: Raffaele Colombo/X